Fidelis Ayebae & family earns $1.01 million in Fidson dividend

Nigerian pharmaceutical mogul Fidelis Ayebae, alongside his family, is set to receive a N1.36 billion ($1.01 million) payout from his stake in Fidson Healthcare Plc, a prominent Lagos-based pharmaceutical manufacturer firm listed on the Nigerian Exchange Group (NGX).

This payout is part of the group’s recommended total dividend of N3.6 billion ($2.67 million) for fiscal year 2025, reflecting the company’s robust financial performance.

The dividend, to be paid on Friday, July 31, 2026, is a testament to Fidson Healthcare Plc’s impressive financial results. The board of directors recommended a dividend of N1.5 ($0.00111) per share for the 2025 fiscal year.

Ayebae’s leadership drives Fidson’s growth
Under Ayebae’s leadership, Fidson has made remarkable strides since its founding in 1995. Today, Ayebae, who holds a 39.39% stake in the company, ranks among Nigeria’s leading investors. He and his family members are poised to receive N1.36 billion ($1.01 million) in dividends, cementing his position as a key figure in the country’s pharmaceutical industry.

Fidson posted impressive results for 2025, with a 124.68% increase in profit, from N4.4 billion ($3.27 million) in 2024 to N9.88 billion ($7.34 million). This performance was driven by a 41.42% surge in revenue, which grew from N84.19 billion ($56.84 million) to N119.06 billion ($88.45 million), particularly thanks to the higher sales of ethical drugs.

Revenue from ethical products alone jumped significantly to N77 billion ($57.74 million), up from N55 billion ($37.14 million). By the close of 2025, Fidson’s total assets grew from N73.3 billion ($50 million) to N80.29 billion ($59.55 million), while total equity rose to N30.2 billion ($22.4 million). These impressive figures reinforce Fidson’s standing as a leader in Nigeria’s competitive pharmaceutical sector.

Fidson dividend 2025 — Fidson Towers, 268 Ikorodu Road, Obanikoro, Lagos, Nigeria

Ayebae and family’s Fidson’s stake delivers more than $1 million payday
Fidson’s strong financial performance prompted its board to propose a dividend of N1.5 ($0.00111) per share, up 57% from the dividend of N1 ($0.0007) per share paid to shareholders in the previous year. This amounts to a total payout of N3.6 billion ($2.67 million), compared to N2.29 billion ($1.49 million) the previous year. The dividend is still subject to shareholder approval at the upcoming AGM and will be paid from the profits earned in the year ending December 31, 2025.

Ayebae, who holds a 31.66% stake in Fidson, equivalent to 759,643,749 shares, stands to receive N1,139,465,623.5 ($846,261.77), while his wife, holding 3.11% indirect shares of Fidson, is poised to pocket N111.94 million ($83,085.7). Another member of the family, Oshoke Ayebae, holding 2.89% stake, will also be getting N103.97 million ($77,150.85). These altogether crossing over $1 million, solidify their position as the largest dividend earner of Fidson and one of the richest healthcare investors on the Nigerian Exchange.